Evidence map›Paper›PMID 29927091›Full record

ArticleCurrent protocols in microbiology2018

Salmonella Typhimurium Infection of Human Monocyte-Derived Macrophages.

Stephanie K Lathrop, Kendal G Cooper, Kelsey A Binder, Tregei Starr, Veena Mampilli, Corrella S Detweiler, Olivia Steele-Mortimer

Abstract read
In one paragraph

Article in Current protocols in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Plant-Derived Phenolic Acids Limit the Pathogenesis ofMolecules (Basel, Switzerland) · 2024
    Article
  3. Frontiers in microbiology · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Comprehensive Single Cell Analyses of the Nutritional Environment of IntracellularFrontiers in cellular and infection microbiology · 2021
    Article
  9. Women in immunology: 2020 and beyond.Nature immunology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Stephanie K LathropLaboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana.
Kendal G CooperLaboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana.
Kelsey A BinderLaboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana.
Tregei StarrLaboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana.
Veena MampilliLaboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana.
Corrella S DetweilerDepartment of Molecular Cellular and Developmental Biology, University of Colorado, Boulder, Colorado.
Olivia Steele-MortimerLaboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana.

Funding

The Salmonella-Containing VacuoleZIAAI000909 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI STEELE-MORTIMER, OLIVIA · 2009 to 2025
$12.9M
Salmonella-Host Cell InteractionsZIAAI001111 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI STEELE-MORTIMER, OLIVIA · 2009 to 2018
$5.6M
Host Responses: Salmonella Enterica Serovar TyphimuriumZ01AI000909 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI STEELE-MORTIMER, OLIVIA · 2002 to 2008
$3.1M
A Novel Screen for Antibacterials that Are Non-Toxic to MammalsR33AI121365 · NIAID · UNIVERSITY OF COLORADO · PI DETWEILER, CORRELLA S, WANG, XIANG · 2018 to 2020
$1.4M
A Mammalian Cellular Niche for Chronic BacteriaR21AI076682 · NIAID · UNIVERSITY OF COLORADO · PI DETWEILER, CORRELLA S · 2008 to 2009
$334k
Intramural NIH HHS Z01 AI000909NIAID NIH HHS R21 AI076682NIAID NIH HHS R33 AI121365
6 · The paper itself

Abstract

The successful infection of macrophages by non-typhoidal serovars of Salmonella enterica is likely essential to the establishment of the systemic disease they sometimes cause in susceptible human populations. However, the interactions between Salmonella and human macrophages are not widely studied, with mouse macrophages being a much more common model system. Fundamental differences between mouse and human macrophages make this less than ideal. Additionally, the inability of human macrophage-like cell lines to replicate some properties of primary macrophages makes the use of primary cells desirable. Here we present protocols to study the infection of human monocyte-derived macrophages with Salmonella Typhimurium. These include a method for differentiating monocyte-derived macrophages in vitro and protocols for infecting them with Salmonella Typhimurium, as well as assays to measure the extent of infection, replication, and death. These protocols are useful for the investigation of both bacterial and host factors that determine the outcome of infection. © 2018 by John Wiley & Sons, Inc.

Indexed as

AnimalsCell Culture TechniquesCell DifferentiationCells, CulturedCell SeparationHumansIntestinesMacrophagesMiceMicroscopyMonocytesSalmonella InfectionsSalmonella typhimuriumbacteriainfectionintracellular pathogenmacrophagesmonocyte-derived macrophagesalmonella

Identifiers

PMID29927091
PMCPMC6105500

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.